Endocrine and paracrine regulation of endometrial angiogenesis

Annals of the New York Academy of Sciences

Volumn 943, Issue , 2001, Pages 109-121

  Taylor, Robert N ^a   Lebovic, Dan I ^a,b   Hornung, Daniela ^a,c   Mueller, Michael D ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cytokines; Steroids; Uterus; VEGF

Indexed keywords

ESTRADIOL; INTERLEUKIN 1BETA; STEROID; VASCULOTROPIN;

ADENOCARCINOMA; ANGIOGENESIS; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOCRINE FUNCTION; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MENSTRUAL CYCLE; PARACRINE SIGNALING; UTERUS BLEEDING;

EID: 0034803554     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03795.x     Document Type: Conference Paper

References (48)

1. Angiogenic factors
2. Molecular and biological properties of the vascular endothelial growth factor family of proteins
3. Vascular endothelial growth factor expression in cycling human endometrium
4. The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17beta-oestradiol
5. Menstruation in intraocular endometrial transplants in the rhesus monkey
6. Dating the endometrial biopsy
7. Capillaries and arterioles in normal endometrium
8. Proliferation kinetics of human endometrium during the normal mentrual cycle
9. Endometrial microvascular growth in normal and dysfunctional states
10. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation
11. Angiogenesis in the postovulatory primate endometrium: The coiled arteriolar system
12. Isolation, characterization and comparison of human endometrial and endometriosis cells in vitro
13. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis
14. Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells
15. Neutrophils infiltrating the endometrium express vascular endothelial growth factor: Potential role in endometrial angiogenesis
16. Oestrogen receptor (ER)-α and ER-β isoforms in normal endometrial and endometriosis-derived stromal cells
17. Effects of tamoxifen and ICI 164384 on protein synthesis and vectorial secretion in polarized rat uterine epithelial cells
18. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties
19. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis
20. RANTES derived from normal endometrial and endometriosis stromal cells has altered bio- to immunoactivity
21. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-lbeta
22. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta
23. Vascular endothelial growth factor (VEGF) in endometriosis
24. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans
25. Ovarian steroids and angiogenesis
26. Human umbilical vessels and cultured umbilical vein endothelial and smooth muscle cells lack detectable protein and mRNA encoding estrogen receptors
27. Human umbilical vein endothelial cells lack expression of the estrogen receptor
28. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells
29. Progesterone regulates proliferation of endothelial cells
30. Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro
31. Angiogenesis, vascular endothelial growth factor and the endometrium
32. Endometriosis: Role of ovarian steroids in initiation, maintenance, and suppression
33. Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin)
34. Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium
35. Trophoblast pseudo-vasculogenesis: Faking it with endothelial adhesion receptors
36. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells
37. Immunohistochemical localization of estradiol and progesterone receptors in human uterus throughout pregnancy: Expression in endometrial blood vessel
38. The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing
39. The chicken vitellogenin II gene is flanked by a GATA factor-dependent estrogen response unit
40. Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells
41. A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor
42. Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters
43. Fos-related Antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity
44. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor
45. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer
46. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites
47. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1
48. Response of tumour cells to hypoxia: Role of p53 and NFkB